Correction: Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma
Melanoma is a highly immunogenic malignancy originating from melanocytes and is distinguished by a significantly higher propensity for metastasis compared to other cutaneous cancers (1)(2). This strong immunogenicity is evidenced by dense lymphocytic infiltration within the tumor microenvironment (TME) and an increased...